KR20200009824A - An anti-drunkenness and hangover-alleviating composition and its preparation method - Google Patents
An anti-drunkenness and hangover-alleviating composition and its preparation method Download PDFInfo
- Publication number
- KR20200009824A KR20200009824A KR1020180084737A KR20180084737A KR20200009824A KR 20200009824 A KR20200009824 A KR 20200009824A KR 1020180084737 A KR1020180084737 A KR 1020180084737A KR 20180084737 A KR20180084737 A KR 20180084737A KR 20200009824 A KR20200009824 A KR 20200009824A
- Authority
- KR
- South Korea
- Prior art keywords
- whole
- extract
- flavanone
- weight
- hangover
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 63
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 claims abstract description 61
- 235000011981 flavanones Nutrition 0.000 claims abstract description 61
- 229930003949 flavanone Natural products 0.000 claims abstract description 56
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims abstract description 23
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 17
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 17
- 239000004615 ingredient Substances 0.000 claims abstract 2
- 150000002208 flavanones Chemical class 0.000 claims description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 241000219109 Citrullus Species 0.000 claims description 22
- 239000002775 capsule Substances 0.000 claims description 14
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 claims description 12
- 229920000858 Cyclodextrin Polymers 0.000 claims description 10
- 239000001116 FEMA 4028 Substances 0.000 claims description 10
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 10
- 229960004853 betadex Drugs 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 229940013618 stevioside Drugs 0.000 claims description 6
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 6
- 235000019202 steviosides Nutrition 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000004440 column chromatography Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000001953 recrystallisation Methods 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 239000002075 main ingredient Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000003801 milling Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002781 deodorant agent Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 150000002207 flavanone derivatives Chemical class 0.000 abstract 3
- 244000241235 Citrullus lanatus Species 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000035622 drinking Effects 0.000 description 33
- 208000002173 dizziness Diseases 0.000 description 17
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 150000002212 flavone derivatives Chemical class 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 235000013405 beer Nutrition 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 235000020097 white wine Nutrition 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005453 pelletization Methods 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YTAQZPGBTPDBPW-UHFFFAOYSA-N 2-phenylchromene-3,4-dione Chemical compound O1C2=CC=CC=C2C(=O)C(=O)C1C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 2
- 206010053164 Alcohol withdrawal syndrome Diseases 0.000 description 2
- 208000029650 alcohol withdrawal Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
본 발명은 약학 분야, 특히 취기-제거(anti-drunkenness) 및 숙취-완화(hangover-alleviating) 기능을 갖는 조성물 및 이의 제조 방법에 관한 것이다.The present invention relates to the pharmaceutical field, in particular to compositions having anti-drunkenness and hangover-alleviating functions and methods for their preparation.
적당한 음주는 사람의 신체 건강에 유익하다. 그러나, 과도한 음주는 취기 및 현기증(dizziness), 두통(headache), 숙취(hangover), 및 음주 후 무례한 행위의 출현을 유발할 수 있고, 정상적인 업무 및 대인 관계에 영향을 줄 수 있다. 더욱 심각한 것은 과도한 음주가 또한 신체 조직 및 기관을 손상시킬 수 있다는 것이다. 예를 들어, 지속적인 과도한 음주는 간 세포를 손상시킬 수 있고 간의 정상적인 대사를 방해할 수 있으며, 추가로 알코올성 간염(hepatitis) 및 간경변(cirrhosis)을 야기할 수 있다. 또한, 빈번한 음주는 알코올 의존을 유발할 수 있고, 즉, 갑자기 음주를 중단하거나 또는 알코올 섭취를 감소시킨 후 다양한 불편한 신체 증상이 나타날 것이고, 이는 또한 알코올 금단 증후군(alcohol withdrawal syndrome)으로 알려져 있다.Moderate drinking is beneficial to a person's physical health. However, excessive drinking can cause odor and dizziness, headaches, hangovers, and the appearance of rude behavior after drinking, and can affect normal work and interpersonal relationships. More seriously, excessive drinking can also damage body tissues and organs. For example, persistent excessive drinking can damage liver cells, interfere with normal metabolism of the liver, and can further cause alcoholic hepatitis and cirrhosis. In addition, frequent drinking may lead to alcohol dependence, that is, various uncomfortable physical symptoms will occur after sudden stop drinking or reducing alcohol intake, also known as alcohol withdrawal syndrome.
따라서, 사람은 음주로 인해 유발된 불편함을 완화시키기 위해 다양한 방법을 채택하고 있고, 또한 시장에서는 대응하는 많은 시판 제품도 있지만, 그러나 대부분의 제품은 부정확한 치료 효과가 있다. Thus, a person adopts various methods to alleviate the inconvenience caused by drinking, and there are also many commercially available products on the market, but most products have an inaccurate therapeutic effect.
상기 문제점을 해결하기 위해서, 본 발명은 다수의 실험에 기초하여 새로운 취기-제거 및 숙취-완화용 조성물을 제안한다. 상기 조성물은 음주자의 음주 한계값(threshold value)을 유의하게 향상시킬 수 있고, 취기 및 취기로 인해 유발된, 현기증, 통제-불능 행동 등과 같은 신체적 불편감을 방지할 수 있고, 대상체의 알코올 금단 증후군을 완화시킬 수 있다. 또한, 상기 조성물은 알코올의 분해를 촉진시킬 수 있고 간 세포에서 알코올의 손상을 완화시킬 수 있는 간-보호 성분을 포함하고, 이상적인 취기-제거 및 숙취-완화용 제품이다.In order to solve the above problems, the present invention proposes a new odor-removing and hangover-releasing composition based on a number of experiments. The composition can significantly improve the drinking threshold value of the drinker, can prevent physical discomfort such as dizziness, uncontrollable behaviors caused by odor and odor, and prevent alcohol withdrawal syndrome of the subject Can be mitigated. The composition also contains a liver-protective component that can promote the breakdown of alcohol and mitigate the damage of alcohol in liver cells, and is an ideal odor-removing and hangover-releasing product.
발명의 요약Summary of the Invention
상기 기술적인 목적을 달성하기 위해, 본 발명은 하기의 기술적인 해결책을 채택한다:In order to achieve the above technical object, the present invention adopts the following technical solution:
취기-제거 및 숙취-완화용 조성물은, 수박 껍질 전체의 플라바논(flavanone) 추출물, 목단피(Cortex Moutan) 전체의 플라바논 추출물 및 오미자(Schisandra chinensis) 전체의 플라바논 추출물로부터 선택된 하나 이상을 포함하는 주성분을 포함한다.The odor-removing and hangover-releasing composition comprises at least one selected from flavanone extract of whole watermelon peel, flavanone extract of whole Cortex Moutan and flavanone extract of whole Schisandra chinensis. Contains the main ingredient.
바람직하게는, 주성분은, 수박 껍질 전체의 플라바논 추출물 0-40 중량부, 목단피 전체의 플라바논 추출물 0-40 중량부 및 오미자 전체의 플라바논 추출물 20-100 중량부를 포함한다.Preferably, the main component comprises 0-40 parts by weight of flavanone extract of the whole watermelon peel, 0-40 parts by weight of flavanone extract of the whole bark and 20-100 parts by weight of flavanone extract of the whole Schisandra chinensis.
바람직하게는, 수박 껍질 전체의 플라바논 추출물 내 총 플라바논 함량은 >50%이며, 목단피 전체의 플라바논 추출물 내 총 플라바논 함량은 >80%이고, 오미자 전체의 플라바논 추출물 내 총 플라바논 함량은 >80%이다.Preferably, the total flavanone content in the flavanone extract of the whole watermelon peel is> 50%, the total flavanone content in the flavanone extract of the whole bark skin is> 80%, and the total flavanone content in the flavanone extract of the whole Schizandra chinensis Is> 80%.
수박 껍질 전체의 플라바논 추출물, 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물은 하기의 방법으로 제조된다:The flavanone extract of the whole watermelon peel, the flavanone extract of the whole bark, and the flavanon extract of the whole Schisandra chinensis were prepared by the following method:
수박 껍질, 목단피 및 오미자를 분쇄(pulverizing)하는 단계; 분쇄된 생성물을 70% 미만의 농도에서 물 또는 에탄올로 각각 추출하는 단계; 상기 추출된 용액을 회수하는 단계; 원심 분리하는 단계; 추출, 거대다공성 수지(macroporous resin) 칼럼 크로마토그래피 또는 재결정(recrystallization)을 수행하는 단계; 40-50℃에서의 진공 건조하는 단계; 및 각각의 추출물의 내용물이 요구 사항을 충족시키는 지 확인하기 위해 검출하는 단계.Pulverizing watermelon peel, bark skin and schizandra; Extracting the milled product with water or ethanol, respectively, at a concentration of less than 70%; Recovering the extracted solution; Centrifuging; Performing extraction, macroporous resin column chromatography or recrystallization; Vacuum drying at 40-50 ° C .; And detecting to ensure that the contents of each extract meet the requirements.
본 발명의 취기-제거 및 숙취-완화 조성물은 β-사이클로덱스트린(β-cyclodextrin), 말토덱스트린(maltodextrin) 및 스테비오사이드(stevioside)로부터 선택되는 하나 이상을 포함하는 보조성분을 추가로 포함한다.The odor-removing and hangover-releasing composition of the present invention further comprises an auxiliary component comprising one or more selected from β-cyclodextrin, maltodextrin and stevioside.
바람직하게는, 주성분 및 보조성분의 중량비는 1:(0-3)이다.Preferably, the weight ratio of the main component and the auxiliary component is 1: (0-3).
본 발명은 또한 하기의 단계들을 포함하는, 취기-제거 및 숙취-완화용 조성물을 제조하는 방법을 개시한다:The present invention also discloses a method of preparing a composition for odor-removing and hangover-relieving, comprising the following steps:
(1) 수박 껍질, 목단피 및 오미자를 분쇄하고; 분쇄된 생성물을 70% 미만의 농도로 물 또는 에탄올로 각각 추출하고; 상기 추출된 용액을 회수하고; 원심 분리하고; 추출, 침강(sedimentation), 거대다공성 수지 칼럼 크로마토그래피 또는 재결정을 수행하고; 40-50℃에서 진공 건조하고; 각 추출물의 함량이 요구사항을 충족하는지 확인하기 위해 검출하여 수박 껍질 전체의 플라바논 추출물, 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물을 수득하며; 각각의 추출물을 분쇄하고, 60-메쉬 체(mesh sieve)로 체질(sieving)하는 단계; (1) crushed watermelon peel, bark skin and schizandra; The ground product was extracted with water or ethanol, respectively, at a concentration of less than 70%; Recovering the extracted solution; Centrifugation; Extraction, sedimentation, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; Detection to obtain that the content of each extract satisfies the requirements to obtain a flavanone extract of the whole watermelon peel, a flavanone extract of the whole bark and a flavanone extract of the whole Schisandra chinensis; Milling each extract and sieving with a 60-mesh sieve;
(2) 수박껍질 전체의 플라바논 추출물 0-40 중량부, 오미자 전체의 플라바논 추출물 0-40 중량부, 및 오미자 전체의 플라바논 추출물 20-100 중량부를 칭량(weighing)하고, 이들을 균일하게 혼합하여 주성분을 수득하는 단계; (2) Weighing 0-40 parts by weight of flavanone extract of whole watermelon peel, 0-40 parts by weight of flavanone extract of whole Schisandra chinensis, and 20-100 parts by weight of flavanone extract of whole Schisandra chinensis, and mixing them uniformly To obtain a main component;
(3) β-사이클로덱스트린 0-100 중량부 및 말토덱스트린 0-100 중량부를 칭량하고, 이들을 주성분과 균일하게 혼합하고, 총 중량을 기준으로 10-50%의 물을 첨가하여 반복적으로 그라인딩(grinding)하고, 진공 건조하고, 분쇄하고, 60-메쉬 체로 체질하는 단계; 및(3) 0-100 parts by weight of β-cyclodextrin and 0-100 parts by weight of maltodextrin, weighed and mixed uniformly with the main components, and repeatedly grinding by adding 10-50% water based on the total weight. ), Vacuum dried, milled and sieved to a 60-mesh sieve; And
(4) 스테비오사이드(stevioside) 0-20 중량부를 첨가하고, 균일하게 혼합하고, 멸균하고, 펠렛화(pelleting)하며, 캡슐, 정제 또는 연약(electuary)으로 조제하는 단계.(4) Add 0-20 parts by weight of stevioside, mix uniformly, sterilize, pelletize, and prepare into capsules, tablets or electuary.
본 발명에 기술된 취기-제거 및 숙취-완화용 조성물은 주성분으로서 오미자를 포함하고, 보조성분으로서 수박 껍질 및 오미자를 포함한다. 지원자에 대한 효과의 관찰에 기초하여, 취기-제거 및 숙취-완화용 조성물은 음주 한계값을 개선하고, 음주 증상을 완화 또는 감소시키는 효과를 갖는 것으로 입증된다.The odor-removing and hangover-releasing composition described in the present invention comprises Schizandra as a main component and watermelon peel and Schizandra as auxiliary components. Based on the observation of the effect on volunteers, the compositions for odor-removing and hangover-relieving are proven to have an effect of improving drinking thresholds and alleviating or reducing drinking symptoms.
이하, 본 발명은 구체적인 실시예와 조합하여 추가로 설명될 것이지만, 본 발명은 이들의 실시예로 한정되지 않을 것이다.Hereinafter, the present invention will be further described in combination with specific examples, but the present invention will not be limited to these examples.
실시예 1Example 1
수박 껍질 전체의 플라바논 추출물, 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물의 제조Preparation of Flavanone Extract of Whole Watermelon Peel, Flavanone Extract of Whole Bark Skin and Flavanone Extract of Schizandra chinensis
대상(target)인 수박 껍질 전체의 플라바논 추출물은 수박 껍질을 분쇄하고; 분쇄된 수박 껍질을 60% 에탄올로 가열 환류 추출하고; 상기 추출된 용액을 회수하고; 원심 분리하고; 상층액을 수집하고; 거대다공성 수지 칼럼 크로마토그래피를 수행하여 전체의 플라본 농축 부분을 수득하고; 용매를 회수하고; 농축하고; 40-50℃에서 진공 건조하고; 총 플라본 함량이 >50%인 것을 확인하기 위해 검출함으로써 제조된다.The flavanone extract of the entire watermelon peel is crushed watermelon peel; The crushed watermelon skin was heated to reflux with 60% ethanol; Recovering the extracted solution; Centrifugation; Supernatant is collected; Macroporous resin column chromatography is performed to obtain a whole flavone concentrated portion; Recover the solvent; Concentrate; Vacuum dried at 40-50 ° C .; Prepared by detection to confirm that the total flavone content is> 50%.
대상인 목단피 전체의 플라바논 추출물은 목단피를 분쇄하고; 분쇄된 목단피를 40% 에탄올로 초음파 추출하고; 상기 추출된 용액을 회수하고; 원심분리하고; 상층액을 수집하고; 에틸 아세테이트(ethyl acetate)를 사용한 추출을 수행하여 전체의 플라본 농축 부분을 수득하고; 용매를 회수하고; 농축하고; 40-50℃에서 진공 건조하고; 총 플라본 함량이 >80%인 것을 확인하기 위해 검출함으로써 제조된다.Flavanone extracts of the whole bark of the subject pulverize the bark; The pulverized neck skin was ultrasonically extracted with 40% ethanol; Recovering the extracted solution; Centrifugation; Supernatant is collected; Extraction with ethyl acetate is carried out to obtain the entire flavone concentrate; Recover the solvent; Concentrate; Vacuum dried at 40-50 ° C .; Prepared by detection to confirm that the total flavone content is> 80%.
대상인 오미자 전체의 플라바논 추출물은 오미자를 분쇄하고; 분쇄된 오미자를 60% 에탄올로 가열 환류 추출하고; 상기 추출된 용액을 회수하고; 원심 분리하고; 상층액을 수집하고; 재결정을 수행하여 전체의 플라본 농축 부분을 수득하고; 40-50℃에서 진공 건조하고; 총 플라본 함량이 >80%인 것을 확인하기 위해 검출함으로써 제조된다.Flavanone extracts of the whole Schizandra chinensis are crushed Schizandra; Milled Schizandra chinensis was heated to reflux with 60% ethanol; Recovering the extracted solution; Centrifugation; Supernatant is collected; Recrystallization is carried out to obtain a whole flavone enriched portion; Vacuum dried at 40-50 ° C .; Prepared by detection to confirm that the total flavone content is> 80%.
실시예 2Example 2
취기-제거 및 숙취-완화 캡슐은, 주성분으로서 수박 껍질 전체의 플라바논 추출물, 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물을 포함하고, 보조성분으로서 β-사이클로덱스트린을 포함하며; 하기의 단계를 통해 제조된다:The odor-removing and hangover-releasing capsules include, as main components, flavanon extracts of whole watermelon peel, flavanon extracts of whole bark, and flavanon extracts of whole Schisandra chinensis, and β-cyclodextrin as a secondary component; It is prepared through the following steps:
(1) 갈근(Purerariae lobatae) 전체의 플라바논 추출물 500g, 실시예 1에서 제조된 목단피 전체의 플라바논 추출물 500g 및 오미자 전체의 플라바논 추출물 5000g을 칭량하고, 분쇄하고, 60-메쉬 체로 체질하며; β-사이클로덱스트린 4000g을 칭량하고, 상기 물질들을 균일하게 혼합하는 단계.(1) Weighing 500 g of flavanone extract of whole Purerariae lobatae, 500 g of flavanone extract of whole bark skin prepared in Example 1, and 5000 g of flavanone extract of whole Schisandra chinensis, pulverized, and sieved with a 60-mesh sieve; Weighing 4000 g β-cyclodextrin and mixing the materials uniformly.
(2) 물 3000ml을 첨가하고, 반복적으로 그라인딩하고, 수분 함량이 <5%가 될 때까지 40-50℃에서 진공 건조하고, 분쇄하고, 60-메쉬 체로 체질하는 단계;(2) adding 3000 ml of water, grinding repeatedly, vacuum drying at 40-50 ° C. until the moisture content is <5%, pulverizing and sieving with a 60-mesh sieve;
(3) 멸균을 수행한 후, 20-40% 습도의 환경 하에 펠렛화하여 20-40 메쉬의 입자를 수득하는 단계; 및(3) after performing sterilization, pelletizing in an environment of 20-40% humidity to obtain 20-40 mesh of particles; And
(4) 50% 이하의 습도를 갖는 환경 하에서 입자를 캡슐에 충전하여 각각 0.5g의 중량을 갖는, 캡슐을 수득하는 단계.(4) filling the capsules with the particles under an environment having a humidity of 50% or less to obtain capsules each having a weight of 0.5 g.
투여 방법 및 용량: 경구 투여, 매회 2 캡슐, 음주 30분 전에 따뜻한 물로 투여.Method of administration and dose: Oral administration, 2 capsules each time, 30 minutes before drinking with warm water.
실시예 3Example 3
취기-제거 및 숙취-완화용 연약은, 주성분으로서 오미자 전체의 플라바논 추출물을 포함하고, 보조성분으로서 β-사이클로덱스트린, 말토덱스트린 및 스테비오사이드를 포함하고; 하기의 단계들을 통해 제조된다:The odor-removing and hangover-relieving softeners include flavanone extracts of whole Schisandra chinensis as main components and β-cyclodextrin, maltodextrin and stevioside as auxiliary components; Prepared through the following steps:
(1) 실시예 1에서 제조된 오미자 전체의 플라바논 추출물 5000g을 칭량하고, β-사이클로덱스트린 5000g 및 말토덱스트린 5000g을 칭량하고, 상기 물질들을 균일하게 혼합하는 단계.(1) Weighing 5000 g of the total flavanone extract prepared in Example 1, weighing 5000 g of β-cyclodextrin and 5000 g of maltodextrin and mixing the materials uniformly.
(2) 물 5000ml을 첨가하고, 반복적으로 그라인딩하고, 수분 함량이 <5%가 될 때까지 40-50℃에서 진공 건조하고, 분쇄하고, 60-메쉬 체로 체질하는 단계;(2) adding 5000 ml of water, grinding repeatedly, vacuum drying at 40-50 ° C. until the moisture content is <5%, grinding and sieving with a 60-mesh sieve;
(3) 스테비오사이드 1000g을 첨가하고, 균일하게 혼합하고, 멸균을 수행한 후, 20-40% 습도의 환경 하에서 펠렛화하여 20-40 메쉬의 입자를 수득하는 단계; 및(3) adding 1000 g of stevioside, mixing uniformly, and performing sterilization, then pelletizing in an environment of 20-40% humidity to obtain 20-40 mesh of particles; And
(4) 50% 이하의 습도를 갖는 환경 하에서 입자를 봉지(bag)에 충전하여 각각 2g의 무게를 갖는, 봉쇄된 연약을 수득하는 단계.(4) filling the bags into bags under an environment having a humidity of 50% or less to obtain a sealed softener having a weight of 2 g each.
투여 방법 및 용량: 경구 투여, 매회 2봉지, 음주 전 또는 음주 후 30분에(연약이 끓인 물에 의해 용해된 후에) 투여.Method of administration and dose: Oral administration, 2 bags each time, 30 minutes after drinking or after drinking (after the soft solution is dissolved in boiled water).
실시예 4Example 4
취기-제거 및 숙취-완화용 정제(tablet)는, 주성분으로서 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물을 포함하고, 보조성분으로서 β-사이클로덱스트린 및 말토덱스트린을 포함하며; 하기의 단계들을 통해 제조된다:Odor-removing and hangover-relieving tablets include, as main components, flavanone extracts of whole bark skin and flavanone extracts of whole Schisandra chinensis, and β-cyclodextrin and maltodextrin as auxiliary components; Prepared through the following steps:
(1) 실시예 1에서 제조된 목단피 전체의 플라바논 추출물 300g 및 오미자 전체의 플라바논 추출물 2500g을 칭량하고; β-사이클로덱스트린 2500g 및 말토덱스트린 2500g을 칭량하고, 상기 물질들을 균일하게 혼합하는 단계.(1) Weigh 300 g of the entire flavonone extract and 2500 g of the whole flavonone extract prepared in Example 1; Weighing 2500 g of β-cyclodextrin and 2500 g of maltodextrin and mixing the materials uniformly.
(2) 멸균을 수행한 후, 20~40% 습도의 환경 하에서 펠렛화하여 20-40 메쉬의 입자를 수득하고; 정제화하여 0.3g의 무게를 갖는 각각의 정제를 수득하는 단계.(2) after performing sterilization, pelletizing in an environment of 20-40% humidity to obtain 20-40 mesh of particles; Tableting to obtain each tablet having a weight of 0.3 g.
투여 방법 및 용량: 경구 투여, 매회 2-3개의 정제, 음주 전 또는 음주 후 30분에 투여.Dosage method and dose: Oral administration, 2-3 tablets each time, 30 minutes before or after drinking.
시험 실시예 1Test Example 1
실시예 2에서 제조된 취기-제거 숙취-완화용 캡슐의 효과에 대한 관찰Observation on the effect of the odor-removing hangover-releasing capsule prepared in Example 2
캡슐은 30명의 지원자에 의해 테스트 되었다. 이들에게는 음주 30분 전에 2개의 캡슐이 투여되었고, 음주 후 현기증 및 음주 증상이 관찰되었다. 30명의 지원자는 모두 하기 피드백(feedback)을 주었다: 캡슐은 효과적이었고, 음주자의 음주를 유발하는 알코올의 양을 유의하게 증가시킬 수 있었고, 음주 및 음주에 의해 유발되는 현기증 및 통제력-상실된 행동 등과 같은 신체의 불편감을 예방할 수 있었다. 전형적인 예는 하기와 같다:Capsules were tested by 30 volunteers. They were given two capsules 30 minutes before drinking and dizziness and drinking symptoms were observed after drinking. All 30 volunteers gave the following feedback: Capsules were effective, could significantly increase the amount of alcohol causing alcohol drinkers, dizziness and control-induced behaviors caused by alcohol and alcohol The discomfort of the body could be prevented. Typical examples are as follows:
극소량의 맥주를 음주한 후 보통 현기증을 앓았던 40세의 남성 지원자(센(Shen)의 성을 가짐)에게는, 음주 30분 전에 2개의 캡슐이 투여되었고, 52%의 백포도주 100g을 음주한 후 현기증을 감지하지 않았다.A 40-year-old male volunteer (Shen's last name), who usually had dizziness after drinking a small amount of beer, received two capsules 30 minutes before drinking, dizziness after drinking 52 g of 100% white wine. Did not detect it.
4병의 맥주를 음주한 후 보통 현기증을 앓았던 22세의 남성 지원자(푸(Fu)의 성을 가짐)에게는 음주 30분 전에 2개의 캡슐이 투여되었고, 7병의 맥주를 음주한 후 현기증을 감지하지 않았다. A 22-year-old male volunteer (having Fu's last name), who usually had dizziness after drinking four bottles of beer, received two capsules 30 minutes before drinking, and had dizziness after drinking seven bottles of beer. Did not detect.
시험 실시예 2Test Example 2
실시예 3에서 제조된 취기-제거 숙취-완화용 연약의 효과에 대한 관찰.Observation on the effect of the odor-removing hangover-relaxing softener prepared in Example 3.
연약은 5명의 지원자에 의해 테스트되었다. 이들에게는 음주에 의해 유발된 현기증을 감지한 후 2봉지의 연약이 투여되었고, 현기증 증상의 완화 효과가 관찰되었다. 5명의 지원자는 모두 피드백을 주었다: 연약은 효과적이었고, 현기증 증상을 완화시킬 수 있었고 음주 시간을 단축시킬 수 있었다.The soft was tested by five volunteers. After detecting dizziness caused by alcohol, they received two bags of soft medicine and alleviated dizziness symptoms. All five volunteers gave feedback: weakness was effective, relieved dizziness and shortened drinking time.
시험 실시예 3Test Example 3
실시예 4에서 제조된 취기-제거 숙취-완화용 정제의 효과에 대한 관찰Observation on the effect of the odor-removing hangover-relieving tablet prepared in Example 4
캡슐은 16명의 지원자에 의해 테스트되었다. 이들에게는 음주 30분 전에 2개의 캡슐이 투여되었고, 음주 후 현기증 및 음주 증상이 관찰되었다. 이들 중에서, 15명의 지원자는 피드백을 주었다: 정제는 효과적이었고, 음주자의 음주를 유발하는 알코올의 양을 유의하게 증가시킬 수 있었고, 음주 및 음주에 의해 유발되는 현기증 및 통제력-상실된 행동 등과 같은 신체의 불편감을 예방할 수 있었다. 전형적인 예는 하기와 같다:Capsules were tested by 16 volunteers. They were given two capsules 30 minutes before drinking and dizziness and drinking symptoms were observed after drinking. Of these, 15 volunteers gave feedback: tablets were effective, could significantly increase the amount of alcohol that causes the drinker's drinking, and increased the body's body, such as dizziness and loss of control-induced behavior caused by drinking and drinking. Discomfort could be prevented. Typical examples are as follows:
보통 많은 양의 알코올을 음주하고 곧바로 현기증을 감지하는 31세의 남성 지원자(가오(Gao)의 성을 가짐)에게는, 음주 30분 전에 2개의 정제가 투여되었고, 52%의 백포도주 100g을 음주한 후 현기증을 감지하지 않았다.A 31-year-old male volunteer (with Gao's last name), who usually drank a lot of alcohol and immediately detected dizziness, was given two tablets 30 minutes before drinking and 52% of 100% white wine. Did not detect dizziness.
보통 백포도주를 전혀 음주하지 않고 최대 1병의 맥주를 음주한 후 현기증을 앓았던 36세의 남성 지원자(장(Zhang)의 성을 가짐)에게는, 음주 30분 전에 2개의 정제가 투여되었고, 52%의 백포도주 100g을 음주한 후 현기증을 감지하지 않았다.A 36-year-old male volunteer (who had sex with Zhang) who had dizziness after drinking a maximum of one bottle of beer without drinking white wine at all, received two tablets 30 minutes before drinking, 52% After drinking 100g of white wine, did not detect dizziness.
Claims (7)
Anti-deodorant comprising an active ingredient comprising one or more selected from flavanone extract of whole watermelon peel, flavanone extract of whole Cortex Moutan and flavanone extract of whole Schisandra chinensis drunkenness and hangover-alleviating composition.
According to claim 1, wherein the main ingredient is a flavour-containing 0-40 parts by weight of flavanon extract of the whole watermelon peel, 0-40 parts by weight of flavanone extract of the whole bark skin and 20-100 parts by weight of flavanone extract of the whole Schisandra chinensis Removal and hangover-relieving composition.
The total flavanone content of the flavanone extract of the whole watermelon peel is> 50%, the total flavanone content of the flavanone extract of the whole bark skin is> 80%, and the whole of Schisandra chinensis The total flavanone content in the flavanone extract is> 80%.
수박 껍질, 목단피 및 오미자를 분쇄하는(pulverizing) 단계; 분쇄된 생성물(pulverized resultant)을 70% 미만의 농도에서 물 또는 에탄올로 각각 추출하는 단계; 상기 추출된 용액을 회수하는 단계; 원심 분리하는 단계; 추출, 거대다공성 수지(macroporous resin) 칼럼 크로마토그래피 또는 재결정(recrystallization)을 수행하는 단계; 40-50℃에서 진공 건조하는 단계; 및 각각의 추출물의 함량이 요구사항을 충족하는지 확인하기 위해 검출하는 단계.
The odor-removing and hangover-relieving composition according to claim 3, wherein the flavanone extract of the whole watermelon peel, the flavanone extract of the whole bark and the whole flavanone extract of Schizandra chinensis are prepared by the following method:
Pulverizing watermelon peel, bark skin and schizandra; Extracting the pulverized resultant with water or ethanol, respectively, at a concentration of less than 70%; Recovering the extracted solution; Centrifuging; Performing extraction, macroporous resin column chromatography or recrystallization; Vacuum drying at 40-50 ° C .; And detecting to confirm that the content of each extract meets the requirements.
4. The odor-removing agent of claim 3, further comprising an adjuvant ingredient comprising at least one selected from β-cyclodextrin, maltodextrin and stevioside. And hangover-relieving compositions.
The composition for odor-removing and hangover-relieving according to claim 5, wherein the weight ratio of the main component and the auxiliary component is 1: (0-3).
(1) 수박 껍질, 목단피 및 오미자를 분쇄하고; 분쇄된 생성물을 70% 미만의 농도에서 물 또는 에탄올로 각각 추출하고; 상기 추출된 용액을 회수하고; 원심 분리하고; 추출, 거대다공성 수지 칼럼 크로마토그래피 또는 재결정을 수행하고; 40-50℃에서 진공 건조하고; 각 추출물의 함량이 요구사항을 충족하는지 확인하기 위해 검출하여 수박 껍질 전체의 플라바논 추출물, 목단피 전체의 플라바논 추출물 및 오미자 전체의 플라바논 추출물을 수득하며; 각각의 추출물을 분쇄하고, 60-메쉬 체(mesh sieve)로 체질하는 단계;
(2) 수박껍질 전체의 플라바논 추출물 0-04 중량부, 오미자 전체의 플라바논 추출물 0-40 중량부, 및 오미자 전체의 플라바논 추출물 20-100 중량부를 칭량(weighing)하고, 이들을 균일하게 혼합하여 주성분을 수득하는 단계;
(3) β-사이클로덱스트린 0-100 중량부 및 말토덱스트린 0-100 중량부를 칭량하고, 이들을 주성분과 균일하게 혼합하고, 총 중량을 기준으로 10-50%의 물을 첨가하여 반복적으로 그라인딩(grinding)하고, 진공 건조하고, 분쇄하고, 60-메쉬 체로 체질하는 단계; 및
(4) 스테비오사이드(stevioside) 0-20 중량부를 첨가하고, 균일하게 혼합하고, 멸균하고, 펠렛화(pelleting)하며, 캡슐, 정제 또는 연약(electuary)으로 조제하는 단계.A method for preparing a odor-removing and hangover-releasing composition comprising the following steps:
(1) crushed watermelon peel, bark skin and schizandra; The ground product was extracted with water or ethanol, respectively, at a concentration of less than 70%; Recovering the extracted solution; Centrifugation; Extraction, macroporous resin column chromatography or recrystallization is carried out; Vacuum dried at 40-50 ° C .; Detecting to obtain that the content of each extract satisfies the requirements to obtain a flavanone extract of the whole watermelon peel, a flavanone extract of the whole bark and a flavanone extract of the whole Schisandra chinensis; Milling each extract and sieving with a 60-mesh sieve;
(2) Weighing 0-04 parts by weight of flavanone extract of whole watermelon peel, 0-40 parts by weight of flavanone extract of whole Schisandra chinensis, and 20-100 parts by weight of flavanone extract of whole Schisandra chinensis, and mixing them uniformly To obtain a main component;
(3) Weighing 0-100 parts by weight of β-cyclodextrin and 0-100 parts by weight of maltodextrin, mixing them uniformly with the main ingredients, and repeatedly grinding by adding 10-50% water based on the total weight. ), Vacuum dried, milled and sieved to a 60-mesh sieve; And
(4) Add 0-20 parts by weight of stevioside, mix uniformly, sterilize, pelletize, and prepare into capsules, tablets or electuary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180084737A KR20200009824A (en) | 2018-07-20 | 2018-07-20 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180084737A KR20200009824A (en) | 2018-07-20 | 2018-07-20 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200009824A true KR20200009824A (en) | 2020-01-30 |
Family
ID=69321854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180084737A KR20200009824A (en) | 2018-07-20 | 2018-07-20 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200009824A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023153777A1 (en) * | 2022-02-08 | 2023-08-17 | 한국 한의학 연구원 | Composition for hangover relief comprising cucumis melo l. extract as active ingredient |
CN117770451A (en) * | 2024-02-28 | 2024-03-29 | 北京逯博士行为医学科技研究院有限公司 | Preparation method of anti-alcohol composition |
-
2018
- 2018-07-20 KR KR1020180084737A patent/KR20200009824A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023153777A1 (en) * | 2022-02-08 | 2023-08-17 | 한국 한의학 연구원 | Composition for hangover relief comprising cucumis melo l. extract as active ingredient |
CN117770451A (en) * | 2024-02-28 | 2024-03-29 | 北京逯博士行为医学科技研究院有限公司 | Preparation method of anti-alcohol composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107050148B (en) | Traditional Chinese medicine composition for dispelling effects of alcohol and protecting liver and preparation method thereof | |
KR101898688B1 (en) | Composition for preventing, treating or improving muscle atrophy comprising complex extracts | |
JP4413995B2 (en) | Medicinal plant extract with anti-obesity effect | |
CN104206949A (en) | Composition for improving osteoporosis and increasing bone mineral density, preparation method of same and application of the same in preparation of health-caring product | |
CN104306617A (en) | Maca and Acai-containing composition as well as preparation method and application thereof | |
CN104886576A (en) | Female healthcare food and preparation method thereof | |
CN106310236A (en) | Antioxidation SOD oral spray and preparing method thereof | |
WO2010037256A1 (en) | Composition for reducing blood fat and blood glucose | |
KR20200009824A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
CN104815138A (en) | Immature bitter orange extract, preparation and application | |
CN104982597B (en) | A kind of multi-functional composite instant tea and its preparation method and application | |
CN103006922A (en) | Composition having function of relieving alcoholism to protect liver | |
CN104940263A (en) | Composition with functions of alleviating hangover and protecting liver and preparation method of composition | |
CN115444922A (en) | Anti-fatigue medicinal and edible composition and application thereof | |
DE102018115517A1 (en) | Anti-intoxication and hangover mitigating composition and its preparation process | |
CN103705561A (en) | American ginseng berry pharmaceutical composition and preparation method and application thereof | |
CN104622993B (en) | Chewable tablet with protective effect on alcoholic liver injuries and preparation method of chewable tablet | |
CN104784371A (en) | Pharmaceutical composition for resisting alcoholic liver injury and preparation method thereof | |
KR20200020287A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
JP2020007250A (en) | Anti-drunkenness and hangover-mitigating composition, and method of preparing the same | |
KR20200022771A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
KR20200017870A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
KR20230058792A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
CN104397289A (en) | Teabag for relieving vomitus gravidarum and preparation method thereof | |
KR20200005217A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |